BioCentury
ARTICLE | Financial News

Abingworth closes L225 million fund

February 28, 2014 1:51 AM UTC

Abingworth closed its tenth life sciences venture fund, Abingworth Bioventures VI, with L225 million ($374.7 million), above the fund's L200 million ($333 million) target. Abingworth said it plans to make investments of L5-L20 million ($8.3-$33.3 million) in 15-20 companies. The firm has over $1.3 billion under management and invests in public and private U.S. and European life sciences and healthcare companies across all stages of development. ...